Sheffield oncologist honoured for UK-wide contribution to cancer vaccine research
A cancer specialist at Weston Park Cancer Centre has won a national award for her contribution to UK cancer vaccine research. Professor Sarah Danson
is consultant medical oncologist at Sheffield Teaching Hospitals NHS Foundation Trust and professor of medical oncology at the University of Sheffield. Following a public vote, she received the award at the Great National Cancer Vaccine Summit.
As co-clinical lead of the UK Vaccine Innovation Pathway for cancer since 2023, Professor Danson has provided clinical leadership, vision and insight in support of the development of personalised cancer vaccines for patients. This has led to 30 cancer vaccine trials being adopted onto the National Institute for Health and Care Research portfolio in 11 tumour types, with nearly 2,000 cancer patients recruited into clinical trials testing the vaccines across 85 UK-wide sites. Her efforts have also resulted in a 500 per cent increase in recruitment for UK cancer vaccine trials over the past year.
Read this report on page 22 of the August 2025 issue of RAD Magazine.
The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.
